ABCL vs. OSCR
ABCL (AbCellera Biologics Inc.) and OSCR (Oscar Health, Inc.) are both stocks. Both are in the Healthcare sector — ABCL in Biotechnology, OSCR in Healthcare Plans. Over the past 5 years, ABCL returned -17.75%/yr vs 13.02%/yr for OSCR. Their 0.26 correlation means their historical movements had little consistent relationship.
Performance
ABCL vs. OSCR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ABCL achieves a 66.96% return, which is significantly lower than OSCR's 117.26% return.
ABCL
- 1D
- 0.35%
- 1M
- -29.59%
- 6M
- 57.73%
- YTD
- 66.96%
- 1Y
- 34.67%
- 3Y*
- -7.74%
- 5Y*
- -17.75%
- 10Y*
- —
- ALL TIME*
- -34.32%
OSCR
- 1D
- -0.03%
- 1M
- -2.98%
- 6M
- 117.56%
- YTD
- 117.26%
- 1Y
- 129.90%
- 3Y*
- 60.93%
- 5Y*
- 13.02%
- 10Y*
- —
- ALL TIME*
- -2.60%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $27.22M | $36.48M | $44.45M | |
| $128.55M | $136.76M | $181.50M |
ABCL vs. OSCR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
ABCL AbCellera Biologics Inc. | 66.96% | 16.72% | -48.69% | -43.63% | -29.16% | -62.37% |
OSCR Oscar Health, Inc. | 117.26% | 6.92% | 46.89% | 271.95% | -68.66% | -78.19% |
Correlation
The correlation between ABCL and OSCR is 0.24, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.24 |
Correlation (3Y) Balances recent behavior with more history. | 0.21 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.26 |
Correlation (All Time) Calculated using the full available price history since Mar 3, 2021 | 0.26 |
Fundamentals
ABCL:
$1.74B
OSCR:
$8.09B
ABCL:
-$0.48
OSCR:
-$0.14
ABCL:
21.64
OSCR:
0.68
ABCL:
1.84
OSCR:
6.19
ABCL:
$79.21M
OSCR:
$13.30B
ABCL:
$70.89M
OSCR:
$895.79M
ABCL:
-$166.07M
OSCR:
$19.23M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ABCL vs. OSCR — Risk / Return Rank
ABCL
OSCR
ABCL vs. OSCR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AbCellera Biologics Inc. (ABCL) and Oscar Health, Inc. (OSCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ABCL | OSCR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.37 | ||
| Sortino ratioReturn per unit of downside risk | -1.43 | ||
| Omega ratioGain probability vs. loss probability | 1.12 | 1.30 | -0.17 |
| Calmar ratioReturn relative to maximum drawdown | 0.51 | 2.38 | -1.87 |
| Martin ratioReturn relative to average drawdown | 0.91 | 4.92 | -4.01 |
Loading charts...
Drawdowns
ABCL vs. OSCR - Drawdown Comparison
The maximum ABCL drawdown since its inception was -96.84%, roughly equal to the maximum OSCR drawdown of -94.15%. Use the drawdown chart below to compare losses from any high point for ABCL and OSCR.
Loading charts...
Drawdown Indicators
| ABCL | OSCR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.84% | -94.15% | -2.69% |
Max Drawdown (1Y)Largest decline over 1 year | -54.94% | -51.71% | -3.23% |
Max Drawdown (3Y)Largest decline over 3 years | -68.05% | -53.39% | -14.66% |
Max Drawdown (5Y)Largest decline over 5 years | -90.96% | -88.23% | -2.73% |
Current DrawdownCurrent decline from peak | -90.64% | -15.09% | -75.55% |
Average DrawdownAverage peak-to-trough decline | -84.26% | -63.84% | -20.42% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 30.52% | 24.95% | +5.57% |
Volatility
ABCL vs. OSCR - Volatility Comparison
AbCellera Biologics Inc. (ABCL) has a higher volatility of 22.72% compared to Oscar Health, Inc. (OSCR) at 15.53%. This indicates that ABCL's price experiences larger fluctuations and is considered to be riskier than OSCR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ABCL | OSCR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 22.72% | 15.53% | +7.19% |
Volatility (6M)Calculated over the trailing 6-month period | 58.57% | 45.75% | +12.82% |
Volatility (1Y)Calculated over the trailing 1-year period | 77.27% | 70.91% | +6.36% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 67.67% | 80.94% | -13.27% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 70.72% | 79.51% | -8.79% |
Dividends
ABCL vs. OSCR - Dividend Comparison
Neither ABCL nor OSCR has paid dividends to shareholders.
Financials
ABCL vs. OSCR - Financials Comparison
This section allows you to compare key financial metrics between AbCellera Biologics Inc. and Oscar Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ABCL and OSCR have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ABCL has higher volatility (22.72%) compared to OSCR (15.53%). In terms of maximum drawdown, ABCL dropped -96.84% vs OSCR's -94.15%.
OSCR currently has the higher Sharpe Ratio (1.73 vs 0.36), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ABCL and OSCR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer